A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus1
References (15)
- et al.
Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach and colon mucosal lesions
Gastrointest Endosc
(1993) - et al.
Endoscopic aspiration mucosectomy as curative endoscopic surgery: analysis of 24 cases of early gastric cancer
Gastrointest Endosc
(1995) - et al.
An endoscopic technique for resection of small gastrointestinal carcinomas
Gastrointest Endosc
(1996) - et al.
Endoscopic mucosal resection using a partial transparent hood for lesions located tangentially to the endoscope
Gastrointest Endosc
(2000) - et al.
Effectiveness of endoscopic mucosal resection with submucosal saline injection technique for superficial squamous carcinomas of the esophagus
Gastrointest Endosc
(2000) - et al.
Usefulness of endoscopic aspiration mucosectomy as compared with strip biopsy for the treatment of gastric mucosal cancer
Gastrointest Endosc
(1999) - et al.
Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus
Gastroenterology
(2000)
There are more references available in the full text version of this article.
Cited by (194)
Curative criteria for endoscopic treatment of oesophageal adenocarcinoma
2024, Best Practice and Research: Clinical GastroenterologyAdvancing Approaches for Superficial Esophageal Adenocarcinoma: Shifting Toward More Patient-tailored Therapy
2023, Techniques and Innovations in Gastrointestinal EndoscopyMultidisciplinary Evaluation and Management of Early Stage Esophageal Cancer
2020, Surgical Oncology Clinics of North AmericaAblation for Patients With Barrett or Dysplasia
2019, Shackelford's Surgery of the Alimentary Tract: 2 Volume SetA prospective multicenter study using a new multiband mucosectomy device for endoscopic resection of early neoplasia in Barrett's esophagus
2018, Gastrointestinal EndoscopyCitation Excerpt :This also strengthens the belief that endoscopic treatment of early Barrett’s neoplasia should be centralized in expert centers, where potentially severe adverse events can be adequately managed.1 The perforation rate of 1% in this study was comparable with the 0% to 2% perforation rate reported for MBM in BE in other studies.4-8 However, these studies were mainly focused on efficacy outcomes and were underpowered for assessing risk of perforations.
Endoscopic submucosal dissection for early Barrett's neoplasia: a meta-analysis
2018, Gastrointestinal Endoscopy
- 1
Presented at Digestive Diseases Week, May 19-23, 2002, San Francisco, California (Gastrointest Endosc 2002;55:AB113)
Copyright © 2003 Published by Mosby, Inc.